Judith Hahn, PhD

Address550 16th. Street
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Cornell UniversityBS06/1987Statistics and Biometry
    University of California, BerkeleyMA05/1990Biostatistics
    University of California, BerkeleyPhD05/2001Epidemiology

    Collapse Overview 
    Collapse Overview
    I am an Associate Professor in Residence in the HIV, ID, and Global Medicine Division in the Department of Medicine.

    Substance use plays important biological and behavioral roles in health outcomes, and my work consists of epidemiology at the intersection of substance use and infectious diseases. My research team is currently conducting several NIH-funded studies to examine the use of TB prophylaxis in HIV/TB co-infected alcohol users, as well as interventions to reduce drinking and increase antiretroviral therapy adherence. We are using novel biomarkers of alcohol consumption and INH pill-taking to gain objective measurements where self-report is problematic. I am also teaching and mentoring via a K-24 award, and grant-writing courses in Epidemiology and Biostatistics and the UCSF CTSI KL2 Scholars Program.

    Collapse Research 
    Collapse Research Activities and Funding
    Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2)
    NIH/NIAAA U01AA026223Sep 15, 2017 - Aug 31, 2022
    Role: Principal Investigator
    Mobile Technology to Extend Clinic-Based Counseling for HIV+s in Uganda
    NIH/NIAAA U01AA024990Apr 1, 2017 - Mar 31, 2021
    Role: Principal Investigator
    Training in Research Program on Alcohol Use by Persons with or at Risk for HIV
    NIH/NIAAA K24AA022586Sep 15, 2013 - Aug 31, 2018
    Role: Principal Investigator
    URBAN ARCH (3/5) Uganda Cohort TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety tolerability and adherence
    NIH/NIAAA U01AA020776Sep 20, 2011 - Aug 31, 2021
    Role: Principal Investigator
    Changes in Alcohol Consumption in HIV Positives in Uganda
    NIH/NIAAA R01AA018631Jul 15, 2010 - Mar 31, 2014
    Role: Principal Investigator
    Dynamic Modeling of the HCV Epidemic in IDU
    NIH/NIDA K01DA023365Jun 20, 2007 - May 31, 2012
    Role: Principal Investigator
    Measurement of Alcohol Use Among HIV-Positives in Uganda
    NIH/NIAAA R21AA015897Sep 30, 2006 - Aug 31, 2009
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Faculty Mentoring
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mirzazadeh A, Evans JL, Hahn J, Jain J, Briceno A, Shiboski S, Lum PJ, Bentsen C, Davis G, Shriver K, Dimapasoc M, Stone M, Busch MP, Page K. Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement. AIDS Behav. 2017 Nov 22. PMID: 29168067.
      View in: PubMed
    2. Eyawo O, McGinnis KA, Justice AC, Fiellin DA, Hahn J, Williams EC, Gordon AJ, Marshall BDL, Kraemer KL, Crystal S, Gaither JR, Edelman EJ, Bryant KJ, Tate JP. Alcohol and Mortality: Combining Self-reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected. J Acquir Immune Defic Syndr. 2017 Nov 02. PMID: 29112041.
      View in: PubMed
    3. Wang Y, Chen X, Hahn J, Brumback B, Zhou Z, Miguez MJ, Cook RL. Phosphatidylethanol (PEth) in Comparison to Self-Reported Alcohol Consumption among HIV-infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking. Alcohol Clin Exp Res. 2017 Oct 28. PMID: 29080351.
      View in: PubMed
    4. Asiimwe SB, Fatch R, Patts G, Winter M, Lloyd-Travaglini C, Emenyonu N, Muyindike W, Kekibiina A, Blokhina E, Gnatienko N, Kruptisky E, Cheng DM, Samet JH, Hahn J. Alcohol Types and HIV Disease Progression Among HIV-Infected Drinkers Not Yet on Antiretroviral Therapy in Russia and Uganda. AIDS Behav. 2017 Aug 30. PMID: 28856539.
      View in: PubMed
    5. Morris MD, Neilands TB, Andrew E, Maher L, Page KA, Hahn J. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships. Int J Drug Policy. 2017 Oct; 48:54-62. PMID: 28804051.
      View in: PubMed
    6. Fatch R, Emenyonu NI, Muyindike W, Kekibiina A, Woolf-King S, Hahn J. Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda. AIDS Behav. 2017 Jul; 21(7):1812-1824. PMID: 27198557.
      View in: PubMed
    7. Woolf-King SE, Muyindike W, Hobbs MM, Kusasira A, Fatch R, Emenyonu N, Johnson MO, Hahn J. Vaginal Prostate Specific Antigen (PSA) Is a Useful Biomarker of Semen Exposure Among HIV-Infected Ugandan Women. AIDS Behav. 2017 Jul; 21(7):2141-2146. PMID: 27224979.
      View in: PubMed
    8. Adong J, Lindan C, Fatch R, Emenyonu NI, Muyindike WR, Ngabirano C, Winter MR, Lloyd-Travaglini C, Samet JH, Cheng DM, Hahn J. The Relationship Between Spirituality/Religiousness and Unhealthy Alcohol Use Among HIV-Infected Adults in Southwestern Uganda. AIDS Behav. 2017 May 29. PMID: 28555316.
      View in: PubMed
    9. Morris MD, Shiboski S, Bruneau J, Hahn J, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Clin Infect Dis. 2017 Apr 01; 64(7):860-869. PMID: 28362947.
      View in: PubMed
    10. Emenyonu NI, Fatch R, Muyindike WR, Kekibiina A, Woolf-King S, Hahn J. Randomized Study of Assessment Effects on Alcohol Use by Persons With HIV in Rural Uganda. J Stud Alcohol Drugs. 2017 Mar; 78(2):296-305. PMID: 28317511.
      View in: PubMed
    11. Patts GJ, Cheng DM, Emenyonu N, Bridden C, Gnatienko N, Lloyd-Travaglini CA, Ngabirano C, Yaroslavtseva T, Muyindike WR, Weiser SD, Krupitsky EM, Hahn J, Samet JH. Alcohol Use and Food Insecurity Among People Living with HIV in Mbarara, Uganda and St. Petersburg, Russia. AIDS Behav. 2017 Mar; 21(3):724-733. PMID: 27699595.
      View in: PubMed
    12. Kiwanuka N, Ssetaala A, Ssekandi I, Nalutaaya A, Kitandwe PK, Ssempiira J, Bagaya BS, Balyegisawa A, Kaleebu P, Hahn J, Lindan C, Sewankambo NK. Population attributable fraction of incident HIV infections associated with alcohol consumption in fishing communities around Lake Victoria, Uganda. PLoS One. 2017; 12(2):e0171200. PMID: 28207844.
      View in: PubMed
    13. Muyindike WR, Lloyd-Travaglini C, Fatch R, Emenyonu NI, Adong J, Ngabirano C, Cheng DM, Winter MR, Samet JH, Hahn J. Phosphatidylethanol confirmed alcohol use among ART-naïve HIV-infected persons who denied consumption in rural Uganda. AIDS Care. 2017 Nov; 29(11):1442-1447. PMID: 28278568.
      View in: PubMed
    14. Tsui JI, Mirzazadeh A, Hahn J, Maher L, Bruneau J, Grebely J, Hellard M, Kim AY, Shoukry NH, Cox AL, Prins M, Dore GJ, Lauer G, Lloyd AR, Page K. The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males. Drug Alcohol Depend. 2016 Dec 01; 169:156-162. PMID: 27816863.
      View in: PubMed
    15. Thakarar K, Asiimwe SB, Cheng DM, Forman L, Ngabirano C, Muyindike WR, Emenyonu NI, Samet JH, Hahn J. Alcohol Consumption in Ugandan HIV-Infected Household-Brewers Versus Non-Brewers. AIDS Behav. 2016 Oct; 20(10):2408-17. PMID: 27150894; PMCID: PMC5025349 [Available on 10/01/17].
    16. Hahn J, Anton RF, Javors MA. The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice. Alcohol Clin Exp Res. 2016 Nov; 40(11):2292-2295. PMID: 27716960.
      View in: PubMed
    17. Williams EC, Hahn J, Saitz R, Bryant K, Lira MC, Samet JH. Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res. 2016 Oct; 40(10):2056-2072. PMID: 27696523.
      View in: PubMed
    18. Dukes JW, Dewland TA, Vittinghoff E, Olgin JE, Pletcher MJ, Hahn J, Gladstone RA, Marcus GM. Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws. BMJ. 2016 Jun 14; 353:i2714. PMID: 27301557; PMCID: PMC4908314.
    19. Wandera B, Tumwesigye NM, Nankabirwa JI, Mafigiri DK, Parkes-Ratanshi RM, Kapiga S, Hahn J, Sethi AK. Efficacy of a Single, Brief Alcohol Reduction Intervention among Men and Women Living with HIV/AIDS and Using Alcohol in Kampala, Uganda: A Randomized Trial. J Int Assoc Provid AIDS Care. 2017 May/Jun; 16(3):276-285. PMID: 27215561.
      View in: PubMed
    20. Couture MC, Page K, Sansothy N, Stein E, Vun MC, Hahn J. High prevalence of unhealthy alcohol use and comparison of self-reported alcohol consumption to phosphatidylethanol among women engaged in sex work and their male clients in Cambodia. Drug Alcohol Depend. 2016 Aug 01; 165:29-37. PMID: 27251102.
      View in: PubMed
    21. Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn J, Vlahov D, Vittinghoff E, Batki SL. Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men. J Acquir Immune Defic Syndr. 2016 May 01; 72(1):21-30. PMID: 26674372; PMCID: PMC4837026 [Available on 05/01/17].
    22. Riley ED, Evans JL, Hahn J, Briceno A, Davidson PJ, Lum PJ, Page K. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs. Am J Public Health. 2016 May; 106(5):915-7. PMID: 26985620; PMCID: PMC4878116 [Available on 05/01/17].
    23. Hahn J, Emenyonu NI, Fatch R, Muyindike WR, Kekiibina A, Carrico AW, Woolf-King S, Shiboski S. Declining and rebounding unhealthy alcohol consumption during the first year of HIV care in rural Uganda, using phosphatidylethanol to augment self-report. Addiction. 2016 Feb; 111(2):272-9. PMID: 26381193; PMCID: PMC4715487 [Available on 02/01/17].
    24. Carrico AW, Hunt PW, Emenyonu NI, Muyindike W, Ngabirano C, Cheng DM, Winter MR, Samet JH, Hahn J. Unhealthy Alcohol Use is Associated with Monocyte Activation Prior to Starting Antiretroviral Therapy. Alcohol Clin Exp Res. 2015 Dec; 39(12):2422-6. PMID: 26509359; PMCID: PMC4712082 [Available on 12/01/16].
    25. Morris MD, Bates A, Andrew E, Hahn J, Page K, Maher L. More than just someone to inject drugs with: Injecting within primary injection partnerships. Drug Alcohol Depend. 2015 Nov 01; 156:275-81. PMID: 26460140; PMCID: PMC4633359 [Available on 11/01/16].
    26. Asiimwe SB, Fatch R, Emenyonu NI, Muyindike WR, Kekibiina A, Santos GM, Greenfield TK, Hahn J. Comparison of Traditional and Novel Self-Report Measures to an Alcohol Biomarker for Quantifying Alcohol Consumption Among HIV-Infected Adults in Sub-Saharan Africa. Alcohol Clin Exp Res. 2015 Aug; 39(8):1518-27. PMID: 26148140; PMCID: PMC4515166.
    27. Sundararajan R, Wyatt MA, Woolf-King S, Pisarski EE, Emenyonu N, Muyindike WR, Hahn J, Ware NC. Qualitative study of changes in alcohol use among HIV-infected adults entering care and treatment for HIV/AIDS in rural southwest Uganda. AIDS Behav. 2015 Apr; 19(4):732-41. PMID: 25323678; PMCID: PMC4392168.
    28. Woolf-King SE, Fatch R, Emenyonu N, Muyindike W, Carrico AW, Maisto SA, Hahn J. Development and validation of the East Africa Alcohol Expectancy Scale (AFEXS). J Stud Alcohol Drugs. 2015 Mar; 76(2):336-43. PMID: 25785809.
      View in: PubMed
    29. Tsui JI, Evans JL, Lum PJ, Hahn J, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 2014 Dec; 174(12):1974-81. PMID: 25347412; PMCID: PMC4506774.
    30. Bajunirwe F, Haberer JE, Boum Y, Hunt P, Mocello R, Martin JN, Bangsberg DR, Hahn J. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. PLoS One. 2014; 9(12):e113152. PMID: 25436894; PMCID: PMC4249861.
    31. Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn J. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA. PLoS One. 2014; 9(10):e109282. PMID: 25286346; PMCID: PMC4186818.
    32. Parry CD, Morojele NK, Myers BJ, Kekwaletswe CT, Manda SO, Sorsdahl K, Ramjee G, Hahn J, Rehm J, Shuper PA. Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes - a randomised controlled trial protocol. BMC Infect Dis. 2014 Sep 12; 14:500. PMID: 25212696; PMCID: PMC4174635.
    33. Hahn J, Fatch R, Wanyenze RK, Baveewo S, Kamya MR, Bangsberg DR, Coates TJ. Decreases in self-reported alcohol consumption following HIV counseling and testing at Mulago Hospital, Kampala, Uganda. BMC Infect Dis. 2014 Jul 20; 14:403. PMID: 25038830; PMCID: PMC4223423.
    34. Evans JL, Morris MD, Yu M, Page K, Hahn J. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA. Drug Alcohol Depend. 2014 Sep 01; 142:239-44. PMID: 25034898; PMCID: PMC4471952.
    35. Kruse GR, Bangsberg DR, Hahn J, Haberer JE, Hunt PW, Muzoora C, Bennett JP, Martin JN, Rigotti NA. Tobacco use among adults initiating treatment for HIV infection in rural Uganda. AIDS Behav. 2014 Jul; 18(7):1381-9. PMID: 24638166; PMCID: PMC4294428.
    36. Hayes B, Briceno A, Asher A, Yu M, Evans JL, Hahn J, Page K. Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs. BMC Public Health. 2014 Jun 25; 14:645. PMID: 24965699; PMCID: PMC4091768.
    37. Jain J, Evans JL, Briceño A, Page K, Hahn J. Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users. Alcohol Alcohol. 2014 Sep-Oct; 49(5):520-4. PMID: 24939855; PMCID: PMC4128670.
    38. Tracy D, Hahn J, Fuller Lewis C, Evans J, Briceño A, Morris MD, Lum PJ, Page K. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014 May 29; 4(5):e004988. PMID: 24875490; PMCID: PMC4039809.
    39. Santos GM, Emenyonu NI, Bajunirwe F, Rain Mocello A, Martin JN, Vittinghoff E, Bangsberg DR, Hahn J. Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda. Drug Alcohol Depend. 2014 Jan 01; 134:151-157. PMID: 24169501; PMCID: PMC3885244.
    40. Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, Szekeres G, Bangsberg DR, Coates T, Hahn J. Abbreviated HIV counselling and testing and enhanced referral to care in Uganda: a factorial randomised controlled trial. Lancet Glob Health. 2013 Sep; 1(3):e137-45. PMID: 25104262; PMCID: PMC4129546.
    41. Page K, Morris MD, Hahn J, Maher L, Prins M. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S32-8. PMID: 23884063; PMCID: PMC3722077.
    42. Montgomery ME, Fatch RS, Evans JL, Yu M, Davidson PJ, Page K, Hahn J. Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics. J Urban Health. 2013 Jun; 90(3):500-15. PMID: 22744293; PMCID: PMC3665972.
    43. Fatch R, Bellows B, Bagenda F, Mulogo E, Weiser S, Hahn J. Alcohol consumption as a barrier to prior HIV testing in a population-based study in rural Uganda. AIDS Behav. 2013 Jun; 17(5):1713-23. PMID: 22878790; PMCID: PMC3769173.
    44. Woolf-King SE, Steinmaus CM, Reingold AM, Hahn J . The International Journal of Drug and Alcohol Research. An update on alcohol use and risk of HIV infection in sub-Saharan Africa: Meta analysis and future research directions. 2013; 1(2).
    45. Hahn J, Fatch R, Kabami J, Mayanja B, Emenyonu NI, Martin J, Bangsberg DR. Self-Report of Alcohol Use Increases When Specimens for Alcohol Biomarkers Are Collected in Persons With HIV in Uganda. J Acquir Immune Defic Syndr. 2012 Dec 01; 61(4):e63-4. PMID: 23138732; PMCID: PMC3495104.
    46. Asher AK, Hahn J, Couture MC, Maher K, Page K. people who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013 Nov-Dec; 24(6):e35-44. PMID: 23164598; PMCID: PMC3800507.
    47. Page K, Osburn W, Evans J, Hahn J, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP. Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection. Clin Infect Dis. 2013 Feb; 56(3):405-13. PMID: 23090930; PMCID: PMC3540042.
    48. Muyindike W, Fatch R, Steinfield R, Matthews LT, Musinguzi N, Emenyonu NI, Martin JN, Hahn J. Contraceptive use and associated factors among women enrolling into HIV care in southwestern Uganda. Infect Dis Obstet Gynecol. 2012; 2012:340782. PMID: 23082069; PMCID: PMC3469089.
    49. Le Marchand C, Evans J, Page K, Davidson PJ, Hahn J. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013 Jan 01; 127(1-3):143-9. PMID: 22819868; PMCID: PMC3762448.
    50. Hermanstyne KA, Bangsberg DR, Hennessey K, Weinbaum C, Hahn J. The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Public Health (Oxf). 2012 Aug; 34(3):330-9. PMID: 22451327; PMCID: PMC3699061.
    51. Baveewo S, Kamya MR, Mayanja-Kizza H, Fatch R, Bangsberg DR, Coates T, Hahn J, Wanyenze RK. Potential for false positive HIV test results with the serial rapid HIV testing algorithm. BMC Res Notes. 2012 Mar 19; 5:154. PMID: 22429706; PMCID: PMC3392728.
    52. Evans JL, Tsui JI, Hahn J, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012 Feb 15; 175(4):302-8. PMID: 22227793; PMCID: PMC3271816.
    53. Hahn J, Dobkin LM, Mayanja B, Emenyonu NI, Kigozi IM, Shiboski S, Bangsberg DR, Gnann H, Weinmann W, Wurst FM. Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res. 2012 May; 36(5):854-62. PMID: 22150449; PMCID: PMC3310261.
    54. Wurst FM, Thon N, Weinmann W, Tippetts S, Marques P, Hahn J, Alling C, Aradottir S, Hartmann S, Lakshman R. Characterization of sialic acid index of plasma apolipoprotein J and phosphatidylethanol during alcohol detoxification--a pilot study. Alcohol Clin Exp Res. 2012 Feb; 36(2):251-7. PMID: 21933198.
      View in: PubMed
    55. Hahn J, Woolf-King SE, Muyindike W. Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa. Curr HIV/AIDS Rep. 2011 Sep; 8(3):172-80. PMID: 21713433.
      View in: PubMed
    56. Dias PT, Hahn J, Delwart E, Edlin B, Martin J, Lum P, Evans J, Kral A, Deeks S, Busch MP, Page K. Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis. 2011 Aug 02; 11:208. PMID: 21810243; PMCID: PMC3199778.
    57. Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, Sawires S, Bangsberg DR, Coates T, Hahn J. Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One. 2011; 6(7):e21794. PMID: 21750732; PMCID: PMC3130049.
    58. Baveewo S, Ssali F, Karamagi C, Kalyango JN, Hahn J, Ekoru K, Mugyenyi P, Katabira E. Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda. PLoS One. 2011 May 12; 6(5):e19089. PMID: 21589912; PMCID: PMC3093378.
    59. Wanyenze RK, Hahn J, Liechty CA, Ragland K, Ronald A, Mayanja-Kizza H, Coates T, Kamya MR, Bangsberg DR. Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav. 2011 May; 15(4):751-60. PMID: 20431933; PMCID: PMC3082586.
    60. Hahn J, Bwana MB, Javors MA, Martin JN, Emenyonu NI, Bangsberg DR. Biomarker testing to estimate under-reported heavy alcohol consumption by persons with HIV initiating ART in Uganda. AIDS Behav. 2010 Dec; 14(6):1265-8. PMID: 20697796; PMCID: PMC2974914.
    61. Hahn J, Samet JH. Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep. 2010 Nov; 7(4):226-33. PMID: 20814765; PMCID: PMC2938419.
    62. Levy V, Evans JL, Stein ES, Davidson PJ, Lum PJ, Hahn J, Page K. Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Vaccine. 2010 Aug 23; 28(37):5947-51. PMID: 20638453; PMCID: PMC2936506.
    63. Hahn J, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010 Jul; 105(7):1254-64. PMID: 20491725; PMCID: PMC2907461.
    64. Hennessey KA, Bangsberg DR, Weinbaum C, Hahn J. Hepatitis A seroprevalence and risk factors among homeless adults in San Francisco: should homelessness be included in the risk-based strategy for vaccination? Public Health Rep. 2009 Nov-Dec; 124(6):813-7. PMID: 19894423; PMCID: PMC2773944.
    65. Page K, Hahn J, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis. 2009 Oct 15; 200(8):1216-26. PMID: 19764883; PMCID: PMC2821203.
    66. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, Bangsberg DR, Hahn J. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):280-9. PMID: 19521248; PMCID: PMC2815238.
    67. Tsui JI, Vittinghoff E, Hahn J, Evans JL, Davidson PJ, Page K. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):160-3. PMID: 19647375; PMCID: PMC2849721.
    68. Hahn J, Wylie D, Dill J, Sanchez MS, Lloyd-Smith JO, Page-Shafer K, Getz WM. Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. Epidemics. 2009 Mar; 1(1):47-57. PMID: 20445816.
      View in: PubMed
    69. Evans JL, Hahn J, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009 May 01; 101(3):152-7. PMID: 19181458; PMCID: PMC2692897.
    70. Inglez-Dias A, Hahn J, Lum PJ, Evans J, Davidson P, Page-Shafer K. Trends in methamphetamine use in young injection drug users in San Francisco from 1998 to 2004: the UFO Study. Drug Alcohol Rev. 2008 May; 27(3):286-91. PMID: 18368610; PMCID: PMC3747037.
    71. Lum PJ, Hahn J, Shafer KP, Evans JL, Davidson PJ, Stein E, Moss AR. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat. 2008 Mar; 15(3):229-36. PMID: 18233994.
      View in: PubMed
    72. Das-Douglas M, Colfax G, Moss AR, Bangsberg DR, Hahn J. Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003. J Urban Health. 2008 Mar; 85(2):239-49. PMID: 18163214; PMCID: PMC2430118.
    73. Hahn J, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend. 2008 Jan 11; 93(1-2):43-50. PMID: 17980513; PMCID: PMC2247437.
    74. Martinez P, Andia I, Emenyonu N, Hahn J, Hauff E, Pepper L, Bangsberg DR. Alcohol use, depressive symptoms and the receipt of antiretroviral therapy in southwest Uganda. AIDS Behav. 2008 Jul; 12(4):605-12. PMID: 17968651; PMCID: PMC3591721.
    75. Page-Shafer K, Hahn J, Lum PJ. Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS. 2007 Sep 12; 21(14):1967-9. PMID: 17721105.
      View in: PubMed
    76. Hahn J, Maier M, Byakika-Tusiime J, Oyugi JH, Bangsberg DR. Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda. J Int Assoc Physicians AIDS Care (Chic). 2007 Jun; 6(2):83-6. PMID: 17537997.
      View in: PubMed
    77. Bernardin F, Stramer SL, Rehermann B, Page-Shafer K, Cooper S, Bangsberg DR, Hahn J, Tobler L, Busch M, Delwart E. High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology. 2007 Sep 01; 365(2):446-56. PMID: 17493654; PMCID: PMC2001282.
    78. Hahn J. Sex, drugs, and hepatitis C virus. J Infect Dis. 2007 Jun 01; 195(11):1556-9. PMID: 17471423.
      View in: PubMed
    79. Hahn J, Kushel MB, Bangsberg DR, Riley E, Moss AR. BRIEF REPORT: the aging of the homeless population: fourteen-year trends in San Francisco. J Gen Intern Med. 2006 Jul; 21(7):775-8. PMID: 16808781; PMCID: PMC1924700.
    80. Bacon O, Lum P, Hahn J, Evans J, Davidson P, Moss A, Page-Shafer K. Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. Sex Transm Dis. 2006 Apr; 33(4):228-34. PMID: 16565643.
      View in: PubMed
    81. Kittikraisak W, Davidson PJ, Hahn J, Lum PJ, Evans JL, Moss AR, Page-Shafer K. . Incarceration among young injectors in San Francisco: associations with risk for hepatitis C virus infection. Journal of Substance Use. 2006; 4(11):271-281.
    82. Kushel MB, Hahn J, Evans JL, Bangsberg DR, Moss AR. Revolving doors: imprisonment among the homeless and marginally housed population. Am J Public Health. 2005 Oct; 95(10):1747-52. PMID: 16186453; PMCID: PMC1449431.
    83. Ochoa KC, Davidson PJ, Evans JL, Hahn J, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005 Dec 12; 80(3):297-302. PMID: 15961257.
      View in: PubMed
    84. Hahn J, Bangsberg DR, McFarland W, Charlebois ED, Clark RA, Moss AR. HIV seroconversion among the homeless and marginally housed in San Francisco: a ten-year study. J Acquir Immune Defic Syndr. 2004 Dec 15; 37(5):1616-9. PMID: 15577419.
      View in: PubMed
    85. Moss AR, Hahn J, Perry S, Charlebois ED, Guzman D, Clark RA, Bangsberg DR. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004 Oct 15; 39(8):1190-8. PMID: 15486844.
      View in: PubMed
    86. Hall CS, Charlebois ED, Hahn J, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med. 2004 Apr; 19(4):357-65. PMID: 15061745; PMCID: PMC1492202.
    87. Tulsky JP, Hahn J, Long HL, Chambers DB, Robertson MJ, Chesney MA, Moss AR. Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. Int J Tuberc Lung Dis. 2004 Jan; 8(1):83-91. PMID: 14974750.
      View in: PubMed
    88. Lum PJ, Ochoa KC, Hahn J, Page Shafer K, Evans JL, Moss AR. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health. 2003 Jun; 93(6):919-23. PMID: 12773355; PMCID: PMC1447870.
    89. Evans JL, Hahn J, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, Moss AR. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003 Mar; 80(1):137-46. PMID: 12612103; PMCID: PMC3456106.
    90. Shafer KP, Hahn J, Lum PJ, Ochoa K, Graves A, Moss A. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J Acquir Immune Defic Syndr. 2002 Dec 01; 31(4):422-31. PMID: 12447014.
      View in: PubMed
    91. Davidson PJ, Ochoa KC, Hahn J, Evans JL, Moss AR. Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction. 2002 Dec; 97(12):1511-6. PMID: 12472634.
      View in: PubMed
    92. Hahn J, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, Busch MP, Tobler LH, Phelps B, Moss AR. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002 Dec 01; 186(11):1558-64. PMID: 12447730.
      View in: PubMed
    93. Hahn J, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001 Jul; 34(1):180-7. PMID: 11431749.
      View in: PubMed
    94. Ochoa KC, Hahn J, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001 May-Jun; 26(3):453-60. PMID: 11436937.
      View in: PubMed
    95. Moss AR, Hahn J, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med. 2000 Aug; 162(2 Pt 1):460-4. PMID: 10934071.
      View in: PubMed
    96. Tulsky JP, Pilote L, Hahn J, Zolopa AJ, Burke M, Chesney M, Moss AR. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med. 2000 Mar 13; 160(5):697-702. PMID: 10724056.
      View in: PubMed
    97. Seal KH, Ochoa KC, Hahn J, Tulsky JP, Edlin BR, Moss AR. Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention. West J Med. 2000 Jan; 172(1):16-20. PMID: 10695436; PMCID: PMC1070710.
    98. Jasmer RM, Hahn J, Small PM, Daley CL, Behr MA, Moss AR, Creasman JM, Schecter GF, Paz EA, Hopewell PC. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med. 1999 Jun 15; 130(12):971-8. PMID: 10383367.
      View in: PubMed
    99. Moss AR, Hahn J. Invited commentary: needle exchange--no help for hepatitis? Am J Epidemiol. 1999 Feb 01; 149(3):214-6; discussion 217-8. PMID: 9927215.
      View in: PubMed
    100. Bloch KC, Zwerling L, Pletcher MJ, Hahn J, Gerberding JL, Ostroff SM, Vugia DJ, Reingold AL. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med. 1998 Nov 01; 129(9):698-704. PMID: 9841601.
      View in: PubMed
    101. Yeh RW, Ponce de Leon A, Agasino CB, Hahn J, Daley CL, Hopewell PC, Small PM. Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis. 1998 Apr; 177(4):1107-11. PMID: 9534994.
      View in: PubMed
    102. Daley CL, Hahn J, Moss AR, Hopewell PC, Schecter GF. Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy. Am J Respir Crit Care Med. 1998 Jan; 157(1):19-22. PMID: 9445273.
      View in: PubMed
    103. Miranda J, Gross JJ, J.B. P, Hahn J . Mood matters: Negative mood induction activates dysfunctional attitudes in women vulnerable to depression. Cognitive Therapy and Research. 1998; (4):363-376.
    104. Hahn J, Vranizan KM, Moss AR. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 01; 15(2):157-64. PMID: 9241116.
      View in: PubMed
    105. Terrault NA, Zhou S, Combs C, Hahn J, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology. 1996 Dec; 24(6):1327-33. PMID: 8938155.
      View in: PubMed
    106. Zhou S, Terrault NA, Ferrell L, Hahn J, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 1996 Nov; 24(5):1041-6. PMID: 8903372.
      View in: PubMed
    107. Leiser RJ, Mitchell TF, Hahn J, Abrams DI. The role of critical care nurses in euthanasia and assisted suicide. N Engl J Med. 1996 Sep 26; 335(13):972-3; author reply 973-4. PMID: 8786782.
      View in: PubMed
    108. Burack JH, Cohen MR, Hahn J, Abrams DI. Pilot randomized controlled trial of Chinese herbal treatment for HIV-associated symptoms. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 01; 12(4):386-93. PMID: 8673548.
      View in: PubMed
    109. Terrault NA, Holland CC, Ferrell L, Hahn J, Lake JR, Roberts JP, Ascher NL, Wright TL. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg. 1996 Mar; 2(2):132-8. PMID: 9346639.
      View in: PubMed
    110. Pilote L, Tulsky JP, Zolopa AR, Hahn J, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med. 1996 Jan 22; 156(2):161-5. PMID: 8546549.
      View in: PubMed
    111. Hahn J, Zolopa AR, Moss AR, Trachtenberg AL. Tuberculosis transmission in methadone maintenance programs. JAMA. 1995 Apr 26; 273(16):1260. PMID: 7715037.
      View in: PubMed
    112. Kaplan LD, Shiramizu B, Herndier B, Hahn J, Meeker TC, Ng V, Volberding PA, McGrath MS. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. Blood. 1995 Apr 01; 85(7):1727-35. PMID: 7535586.
      View in: PubMed
    113. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995 Apr; 108(4):1143-51. PMID: 7698582.
      View in: PubMed
    114. Burack JH, Hahn J, Saint-Maurice D, Jacobson MA. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy. Arch Intern Med. 1994 Nov 28; 154(22):2589-96. PMID: 7979856.
      View in: PubMed
    115. Zolopa AR, Hahn J, Gorter R, Miranda J, Wlodarczyk D, Peterson J, Pilote L, Moss AR. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA. 1994 Aug 10; 272(6):455-61. PMID: 8040981.
      View in: PubMed
    116. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn J, Bosworth W, Drucker E, Bloom BR. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994 Jun 16; 330(24):1710-6. PMID: 7993412.
      View in: PubMed
    117. Hahn J, Shaw GM. Trends in Down's syndrome prevalence in California, 1983-1988. Paediatr Perinat Epidemiol. 1993 Oct; 7(4):450-60. PMID: 8290384.
      View in: PubMed
    118. Schulman J, Hahn J. Quality control of birth defect registry data: a case study. Public Health Rep. 1993 Jan-Feb; 108(1):91-8. PMID: 8434104; PMCID: PMC1403336.
    119. Hahn J, Schulman J. Cost efficient sampling design for quality control of a birth defects registry. J Clin Epidemiol. 1992 Dec; 45(12):1371-5. PMID: 1460474.
      View in: PubMed
    Judith's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP